MetaCap

Cel-Sci Corporation Company Profile

NYSE: CVMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.21-0.26 (-17.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cel-Sci at a glance

Cel-Sci Corporation (NYSE: CVM) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Vienna, VA. Cel-Sci is led by Mr. Geert R. Kersten Esq.. The company's shares have traded publicly since 1997.

At a market capitalization of $21.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0000725363, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Cel-Sci do?

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Business description based on the company's public filings.

Company information

Legal name
Cel-Sci Corporation
Ticker
NYSE: CVM
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Mr. Geert R. Kersten Esq.
Headquarters
8229 Boone Boulevard, Vienna, VA, United States
Phone
703 506 9460
IPO year
1997
Market cap
$21.28M
SEC CIK
0000725363
Latest annual report
10-K · Dec 29, 2025

Companies similar to Cel-Sci

CVM peer companies
CompanyPrice% ChgMarket capCompare
MGXMetagenomi Therapeutics Inc.0.565-7.95%$21.36Mvs CVM
EVAXEvaxion A/S ADR2.25+10.84%$20.75Mvs CVM
SAENGenenta Science S.p.A. ADR0.5074-9.39%$24.47Mvs CVM
PTHSPelthos Therapeutics Inc.6.38-8.73%$25.08Mvs CVM
INMBINmune Bio Inc.0.827-7.50%$25.60Mvs CVM
LONALeonaBio Inc.2.02-17.89%$26.41Mvs CVM
EXOZeXoZymes Inc.2.91-14.05%$27.42Mvs CVM
ESLAEstrella Immunopharma Inc.0.321-5.70%$14.11Mvs CVM

Related